[Efficacy and tolerance of a combined oral rhinologic agent].
D000818:Animals; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D001583:Benzoxazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001699:Biometry; D002744:Chlorpheniramine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003139:Common Cold / Q000188:drug therapy*; D004285:Dogs; D004338:Drug Combinations; D004361:Drug Tolerance; D006634:Histamine H1 Antagonists / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D009284:Naphthols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014663:Nasal Decongestants / Q000008:administration & dosage* / Q000627:therapeutic use; D010919:Placebos; D013566:Sympathomimetics / Q000008:administration & dosage* / Q000627:therapeutic use; D013997:Time Factors
D001583:Benzoxazoles; D004338:Drug Combinations; D006634:Histamine H1 Antagonists; D007093:Imidazoles; D009284:Naphthols; D014663:Nasal Decongestants; D010919:Placebos; D013566:Sympathomimetics; D002744:Chlorpheniramine; D001241:Aspirin
Wirksamkeit und Verträglichkeit eines kombinierten oralen Rhinologikums.